Acutus Medical, Inc.

OTCPK:AFIB Voorraadrapport

Marktkapitalisatie: US$2.0m

Acutus Medical Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Takeo Mukai

Algemeen directeur

US$496.8k

Totale compensatie

Percentage CEO-salaris65.1%
Dienstverband CEO2.3yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur4.1yrs

Recente managementupdates

Recent updates

Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding

Feb 24
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding

Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower

Dec 20
Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower

Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)

Jul 18
Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)

Acutus files for FDA approval of catheter ablation system AcQBlate

Oct 18

Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M

Aug 11

Acutus Medical sees Q2 revenue above consensus estimate

Jul 21

Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%

Apr 06
Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%

Acutus Medical: A Name To Slowly Accumulate

Sep 04

Acutus Medical, Inc.: Paradigm-Shifting Technology At A Shocking Price

Jul 21

Acutus Medical cleared to start atrial fibrillation IDE trial

May 27

Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report

May 15
Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report

Analyse CEO-vergoeding

Hoe is Takeo Mukai's beloning veranderd ten opzichte van Acutus Medical's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$497kUS$323k

-US$12m

Compensatie versus markt: De totale vergoeding ($USD 496.85K ) Takeo } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 647.72K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Takeo te vergelijken met de prestaties van het bedrijf.


CEO

Takeo Mukai (43 yo)

2.3yrs

Tenure

US$496,847

Compensatie

Mr. Takeo Mukai serves as Chief Financial Officer (CFO) at Acutus Medical, Inc. since January 9, 2023 and serves as its Chief Executive Officer since January 2024 and served as its Senior Vice President si...


Bestuursleden

NaamPositieTenureCompensatieEigendom
John Sheridan
Independent Director3.7yrsUS$82.70k0.035%
$ 690.2
David Bonita
Independent Director8.7yrsUS$68.70k0.042%
$ 816.7
Niamh Pellegrini
Independent Director3.3yrsUS$75.70k0.038%
$ 735.2
Andrew ElBardissi
Independent Director7.3yrsUS$70.70k0.042%
$ 816.7
Shaden Marzouk
Independent Chairperson of the Board4.5yrsUS$73.70k0.042%
$ 816.7
Jason Garland
Independent Director2.3yrsUS$78.70k0.016%
$ 306.8

4.1yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van AFIB wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).